Summary COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of
symptom severity that requires varying amounts of care according to the different stages of …

Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

Background Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the
treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …

Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …

Background There are concerns that the use of non-steroidal anti-inflammatory drugs
(NSAIDs) may increase the risk of adverse outcomes among patients with coronavirus …

The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

Objective To identify whether active use of nonsteroidal antiinflammatory drugs (NSAIDs)
increases susceptibility to developing suspected or confirmed coronavirus disease 2019 …

At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was
speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to …

Aim Recent reports of potential harmful effects of nonsteroidal anti‐inflammatory drugs
(NSAIDs) in treating patients with coronavirus disease 2019 (COVID‐19) have raised great …